Scinai Immunotherapeutics Ltd. (SCNI)
NASDAQ: SCNI · Real-Time Price · USD
0.741
-0.039 (-5.03%)
At close: Mar 9, 2026, 4:00 PM EDT
0.755
+0.014 (1.89%)
After-hours: Mar 9, 2026, 7:46 PM EDT

Scinai Immunotherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
333104332
Upgrade
Market Cap Growth
-10.77%10.12%-74.89%-76.24%34.05%-65.34%
Upgrade
Enterprise Value
4316195559
Upgrade
Last Close Price
0.783.355.9529.60235.00281.00
Upgrade
PS Ratio
2.244.34----
Upgrade
PB Ratio
0.530.29-0.57-5.8644.22-7.13
Upgrade
P/TBV Ratio
1.150.66--44.22-
Upgrade
EV/Sales Ratio
3.434.63----
Upgrade
EV/EBITDA Ratio
-----21.29
Upgrade
EV/EBIT Ratio
-----25.66
Upgrade
Debt / Equity Ratio
0.300.21-4.50-12.2429.52-4.60
Upgrade
Debt / EBITDA Ratio
-----6.87
Upgrade
Net Debt / Equity Ratio
0.170.01-3.43-4.2411.82-3.96
Upgrade
Net Debt / EBITDA Ratio
-0.20-0.02-1.71-0.71-1.126.53
Upgrade
Net Debt / FCF Ratio
-0.24-0.02-1.57-0.92-1.53-0.73
Upgrade
Asset Turnover
0.090.04----
Upgrade
Quick Ratio
0.531.212.946.077.150.15
Upgrade
Current Ratio
0.711.323.066.157.300.17
Upgrade
Return on Equity (ROE)
1791.99%177.37%----
Upgrade
Return on Assets (ROA)
-39.55%-34.92%-27.24%-23.39%-26.97%5.31%
Upgrade
Return on Capital Employed (ROCE)
-86.90%-74.20%-61.90%-44.70%-36.70%-100.80%
Upgrade
Earnings Yield
13.52%168.09%-250.86%-56.18%-18.90%-4.28%
Upgrade
FCF Yield
-222.29%-222.45%-386.66%-78.52%-17.42%-75.55%
Upgrade
Buyback Yield / Dilution
-157.30%-106.41%-107.22%-33.56%-27.37%-35.70%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.